303 related articles for article (PubMed ID: 15721053)
1. Sex steroids and sexual desire in a man with a novel mutation of aromatase gene and hypogonadism.
Carani C; Granata AR; Rochira V; Caffagni G; Aranda C; Antunez P; Maffei LE
Psychoneuroendocrinology; 2005 Jun; 30(5):413-7. PubMed ID: 15721053
[TBL] [Abstract][Full Text] [Related]
2. Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.
Rochira V; Zirilli L; Madeo B; Aranda C; Caffagni G; Fabre B; Montangero VE; Roldan EJ; Maffei L; Carani C
Bone; 2007 Jun; 40(6):1662-8. PubMed ID: 17400043
[TBL] [Abstract][Full Text] [Related]
3. Role of oestrogen in male sexual behaviour: insights from the natural model of aromatase deficiency.
Carani C; Rochira V; Faustini-Fustini M; Balestrieri A; Granata AR
Clin Endocrinol (Oxf); 1999 Oct; 51(4):517-24. PubMed ID: 10583321
[TBL] [Abstract][Full Text] [Related]
4. A novel compound heterozygous mutation of the aromatase gene in an adult man: reinforced evidence on the relationship between congenital oestrogen deficiency, adiposity and the metabolic syndrome.
Maffei L; Rochira V; Zirilli L; Antunez P; Aranda C; Fabre B; Simone ML; Pignatti E; Simpson ER; Houssami S; Clyne CD; Carani C
Clin Endocrinol (Oxf); 2007 Aug; 67(2):218-24. PubMed ID: 17547681
[TBL] [Abstract][Full Text] [Related]
5. Hypogonadism in chronically lead-poisoned men.
Braunstein GD; Dahlgren J; Loriaux DL
Infertility; 1978; 1(1):33-51. PubMed ID: 12265605
[TBL] [Abstract][Full Text] [Related]
6. Dysmetabolic syndrome in a man with a novel mutation of the aromatase gene: effects of testosterone, alendronate, and estradiol treatment.
Maffei L; Murata Y; Rochira V; Tubert G; Aranda C; Vazquez M; Clyne CD; Davis S; Simpson ER; Carani C
J Clin Endocrinol Metab; 2004 Jan; 89(1):61-70. PubMed ID: 14715828
[TBL] [Abstract][Full Text] [Related]
7. Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation.
Holbrook JM; Cohen PG
South Med J; 2003 Jun; 96(6):544-7. PubMed ID: 12938779
[TBL] [Abstract][Full Text] [Related]
8. Sex steroids and sexual desire mechanism.
Rochira V; Zirilli L; Madeo B; Balestrieri A; Granata AR; Carani C
J Endocrinol Invest; 2003; 26(3 Suppl):29-36. PubMed ID: 12834018
[TBL] [Abstract][Full Text] [Related]
9. [Erectile dysfunction and hypogonadism. Is routine endocrine screening necessary?].
Noldus J; Huland H
Urologe A; 1994 Jan; 33(1):73-5. PubMed ID: 8146936
[TBL] [Abstract][Full Text] [Related]
10. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
[TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibition, testosterone, and seizures.
Harden C; MacLusky NJ
Epilepsy Behav; 2004 Apr; 5(2):260-3. PubMed ID: 15123030
[TBL] [Abstract][Full Text] [Related]
12. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
[TBL] [Abstract][Full Text] [Related]
13. Estrogen replacement therapy in a man with congenital aromatase deficiency: effects of different doses of transdermal estradiol on bone mineral density and hormonal parameters.
Rochira V; Faustini-Fustini M; Balestrieri A; Carani C
J Clin Endocrinol Metab; 2000 May; 85(5):1841-5. PubMed ID: 10843162
[TBL] [Abstract][Full Text] [Related]
14. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update.
Petak SM; Nankin HR; Spark RF; Swerdloff RS; Rodriguez-Rigau LJ;
Endocr Pract; 2002; 8(6):440-56. PubMed ID: 15260010
[TBL] [Abstract][Full Text] [Related]
15. The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL.
Doumouchtsis KK; Kostakis AI; Doumouchtsis SK; Grapsa EI; Passalidou IA; Tziamalis MP; Poulakou MV; Vlachos IS; Perrea DN
Hemodial Int; 2008 Jan; 12(1):100-7. PubMed ID: 18271850
[TBL] [Abstract][Full Text] [Related]
16. Androgen therapy in hypogonadotrophic hypogonadism: time course of erotosexual functions.
Eyal A; Ish-Shalom S; Hoch Z; Hochberg Z
Arch Androl; 1988; 20(2):163-9. PubMed ID: 3134862
[TBL] [Abstract][Full Text] [Related]
17. Fugu (Takifugu rubripes) sexual differentiation: CYP19 regulation and aromatase inhibitor induced testicular development.
Rashid H; Kitano H; Lee KH; Nii S; Shigematsu T; Kadomura K; Yamaguchi A; Matsuyama M
Sex Dev; 2007; 1(5):311-22. PubMed ID: 18391543
[TBL] [Abstract][Full Text] [Related]
18. [Hormonal evaluation in infertile men].
Bourcigaux N; Christin-Maître S
Gynecol Obstet Fertil; 2008 May; 36(5):551-6. PubMed ID: 18462981
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age.
Martínez-Jabaloyas JM; Queipo-Zaragozá A; Rodríguez-Navarro R; Queipo-Zaragozá JA; Gil-Salom M; Chuan-Nuez P
Eur Urol; 2007 Dec; 52(6):1760-7. PubMed ID: 17590268
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3.
Barton DL; Wender DB; Sloan JA; Dalton RJ; Balcueva EP; Atherton PJ; Bernath AM; DeKrey WL; Larson T; Bearden JD; Carpenter PC; Loprinzi CL
J Natl Cancer Inst; 2007 May; 99(9):672-9. PubMed ID: 17470735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
